Literature DB >> 8286329

Inhibition and inactivation of the F1 adenosinetriphosphatase from Bacillus PS3 by dequalinium and activation of the enzyme by lauryl dimethylamine oxide.

S R Paik1, J M Jault, W S Allison.   

Abstract

The F1-ATPase from Bacillus PS3 (TF1) hydrolyzes 50 microM ATP in three kinetic phases. An initial burst rapidly decelerates to a partially inhibited, intermediate phase, which, in turn, gradually accelerates to an uninhibited, final steady-state rate. Lauryl dimethylamine oxide (LDAO) stimulates the final rate over 4-fold. The stimulatory effect saturates at about 0.1% LDAO. Under these conditions, the intermediate phase is nearly absent. Dequalinium inhibits TF1 reversibly in the dark in the presence or absence of LDAO. The apparent affinity of TF1 for dequalinium increases in the presence of LDAO. Dixon plots of the initial rates of the intermediate phase and the final rates against dequalinium concentration at a series of fixed ATP concentrations in the presence and absence of 0.03% LDAO indicate noncompetitive inhibition in each case. Replots of the slopes of the Dixon plots for the initial rate of the intermediate phase and the final rate against 1/[ATP] reveal apparent Km values of 770 microM and 144 microM, respectively, when obtained in the absence of LDAO. The apparent Km values determined from the data obtained in the presence of LDAO for the same phases are 303 microM and 163 microM, respectively. These results suggest that LDAO stimulates ATPase activity either by increasing the affinity of noncatalytic sites for ATP, which promotes release of inhibitory MgADP from a catalytic site, or by directly promoting release of MgADP from the affected catalytic site. Dequalinium retards this process without affecting the affinity of noncatalytic sites for ATP. When irradiated in the presence of dequalinium, TF1 is rapidly inactivated with an apparent Kd of 12.5 microM in the presence or absence of LDAO.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8286329     DOI: 10.1021/bi00167a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  alpha3beta3gamma complex of F1-ATPase from thermophilic Bacillus PS3 can maintain steady-state ATP hydrolysis activity depending on the number of non-catalytic sites.

Authors:  T Amano; T Matsui; E Muneyuki; H Noji; K Hara; M Yoshida; T Hisabori
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

Review 2.  Inhibitory Mg-ADP-fluoroaluminate complexes bound to catalytic sites of F(1)-ATPases: are they ground-state or transition-state analogs?

Authors:  W S Allison; H Ren; C Dou
Journal:  J Bioenerg Biomembr       Date:  2000-10       Impact factor: 2.945

3.  Inhibition sites in F1-ATPase from bovine heart mitochondria.

Authors:  Jonathan R Gledhill; John E Walker
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

Review 4.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

5.  Biophysical Characterization of a Thermoalkaliphilic Molecular Motor with a High Stepping Torque Gives Insight into Evolutionary ATP Synthase Adaptation.

Authors:  Duncan G G McMillan; Rikiya Watanabe; Hiroshi Ueno; Gregory M Cook; Hiroyuki Noji
Journal:  J Biol Chem       Date:  2016-09-13       Impact factor: 5.157

6.  Modification of the mitochondrial F1-ATPase epsilon subunit, enhancement of the ATPase activity of the IF1-F1 complex and IF1-binding dependence of the conformation of the epsilon subunit.

Authors:  G Solaini; A Baracca; E Gabellieri; G Lenaz
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

Review 7.  Does the gamma subunit move to an abortive position of ATP hydrolysis when the F1.ADP.Mg complex isomerizes to the inactive F1*.ADP.Mg complex?

Authors:  W S Allison; J M Jault; C Dou; N B Grodsky
Journal:  J Bioenerg Biomembr       Date:  1996-10       Impact factor: 2.945

8.  A functionally inactive, cold-stabilized form of the Escherichia coli F1Fo ATP synthase.

Authors:  Mikhail A Galkin; Robert R Ishmukhametov; Steven B Vik
Journal:  Biochim Biophys Acta       Date:  2006-03-20

9.  The structure of the catalytic domain of the ATP synthase from Mycobacterium smegmatis is a target for developing antitubercular drugs.

Authors:  Alice Tianbu Zhang; Martin G Montgomery; Andrew G W Leslie; Gregory M Cook; John E Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-25       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.